JVJean-Michel H. Vos

Jean-Michel H. Vos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jean-Michel H. Vos has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel L. Svoboda

    UNC-Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

    1 shared publication
  • David C. Thomas

    Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA

    1 shared publication
  • K. Young Truong

    Department of Biostatistics, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599-7295, USA

    1 shared publication
  • Rona S. Scott

    Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA

    1 shared publication
  • Thomas A. Kunkel

    Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, USA

    1 shared publication

Latest Publications

    • 1 April 1999
      • Vol. 1  (2) , 204-15

    Therapeutic mammalian artificial episomal chromosomes.

    by J M Vos

    Two general strategies are being developed to engineer mammalian artificial chromosomes (MACs) as therapeutic vectors: (i) in vitro MAC cloning by enzymatic ligation of the individual MAC components followed by propagation in single cell organisms such as bacteria or yeast; and (ii) in situ MAC assembly by co-introduction of the various MAC elements into an 'incubator' mammalian tissue culture cell and use of it as a 'foster parental' donor cell. Because of their organizational compactness, in vitro built MACs are stuitable for somatic-based human gene therapy. In contrast, the long-term persistence of in situ built MACs can be capitalized on to generate husbandry transgenic animals expressing therapeutic genes. While current MAC systems generally rely on cis-elements exclusively from viral or genomic origin, the next generation of MACs may combine both into chimeric systems. As illustration of the genetic flexibility and technological potential of chimeric MACs, the herpes viral oriP/EBNA1 system, paradigm of a self-replicating and self-segregating episome in human cells is discussed in terms of future therapeutic applications.

  • Open Access

    Replication initiation and elongation fork rates within a differentially expressed human multicopy locus in early S phase

    by Rona S. Scott, K. Young Truong, Jean-Michel H. Vos

    Replication of the 400 copies of the 43 kb human ribosomal RNA (rDNA) locus spans most of the S phase. To examine the basis for the unusual pattern of rDNA replication, a sensitive strategy was developed to map origins of DNA replication and measure apparent rates of fork progression within a chromosomal locus. This technique, termed differential intragenomic replication timing, revealed that initiation within the actively transcribed rDNA occurred in early S within a 10.7 kb region spanning the promoter and 5′ external transcribed spacer. Forks emanating from this early bidirectional origin progressed at an apparent slow rate with the sense and anti-sense forks moving at 0.32 and 0.23 kb/min. Using a photochemical-based technique, the chromatin status of the rDNA repeats was assayed throughout the S phase. Approximately 85% of the rDNA repeats were in a transcriptionally active chromatin structure at the start of S phase. A progressive decrease in the transcription state of the rDNA loci was observed, reaching a minimum between 3 and 6 h in mid S phase. Altogether, the data suggest a link between RNA polymerase I mediated transcription and site-specific initiation of DNA replication within the rDNA multicopy locus.


  • The simplicity of complex MACs

    by Jean-Michel H. Vos

    The development of mammalian artificial chromosomes (MACs) would be useful for biotechnology and biomedicine, including their use in functional genomics, transgenic animals and gene therapy. By analogy to large cloning systems in microorganisms, MACs may be engineered using endogenous chromosomal elements such as the yeast-based artificial chromosomes (YACs), or exogenous extra-chromosomal components derived from viruses and other cellular parasites such as the bacterial-based artificial chromosomes (BACs) and p1 artificial chromosomes (PACs).


  • Open Access

    Strand Specificity of Mutagenic Bypass Replication of DNA Containing Psoralen Monoadducts in a Human Cell Extract

    by David C. Thomas, Daniel L. Svoboda, Jean-Michel H. Vos, Thomas A. Kunkel

    Psoralens are mutagenic compounds of vegetable origin that are used as photosensitizing agents in the treatment of various skin diseases, blood cell cancer, and autoimmune disorders. To study the mechanism of mutagenicity of psoralens in humans, we examined the efficiency and fidelity of simian virus 40 origin-dependent replication in a human cell extract of M13mp2 DNA randomly treated with the psoralen derivative 4'-hydroxymethyl-4,5',8-trimethyl psoralen plus UVA irradiation. Replication of DNA treated with variable amounts of 4'-hydroxymethyl-4,5',8-trimethyl psoralen and a fixed UVA fluence was inhibited in a concentration-dependent manner. However, covalently closed monomer-length circular replication products were observed. Product analysis by renaturing agarose gel electrophoresis after cross-linking with 250- to 280-nm UV light indicated that approximately 1 of 9 psoralen monoadducts was bypassed during in vitro replication. Introduction of product DNA into Escherichia coli to score replication errors in the lacZalpha reporter gene demonstrated that replication of the damaged DNA was more mutagenic than was replication of undamaged DNA. Sequence analysis of lacZ mutants revealed that damage-dependent replication errors were predominantly T.A-->C.G transitions, transversions at C.G base pairs, and deletions of single A.T base pairs, the last occurring most frequently in homopolymeric runs. A comparison of error specificities with two substrates having the replication origin asymmetrically placed on opposite sides of the mutational target suggests that the lagging-strand replication apparatus is less accurate than the leading-strand replication apparatus for psoralen monoadduct-dependent deletion errors. A model is proposed based on the preferential loopout of the monoadducted base from the strand that templates retrograde discontinuous synthesis.